| Secondary |
| Benign Prostatic Hyperplasia |
57.9% |
| Drug Use For Unknown Indication |
23.7% |
| Antiretroviral Therapy |
5.3% |
| Hiv Infection |
5.3% |
| Anxiety Disorder |
2.6% |
| Convulsion |
2.6% |
| Ill-defined Disorder |
2.6% |
|
| Jaundice |
36.8% |
| Aspartate Aminotransferase Increased |
5.3% |
| Choroidal Detachment |
5.3% |
| Drug Interaction |
5.3% |
| Dysuria |
5.3% |
| International Normalised Ratio Increased |
5.3% |
| Paraesthesia |
5.3% |
| Post Procedural Haemorrhage |
5.3% |
| Swelling |
5.3% |
| Thinking Abnormal |
5.3% |
| Troponin T Increased |
5.3% |
| Urine Flow Decreased |
5.3% |
| Visual Field Defect |
5.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
33.1% |
| Drug Use For Unknown Indication |
21.1% |
| Prophylaxis |
5.8% |
| Supplementation Therapy |
4.4% |
| Benign Prostatic Hyperplasia |
4.2% |
| Hypertension |
4.1% |
| Pain |
3.2% |
| Cardiac Disorder |
2.8% |
| Blood Cholesterol Increased |
2.7% |
| Atrial Fibrillation |
2.3% |
| Back Pain |
2.3% |
| Non-small Cell Lung Cancer |
2.0% |
| Depression |
2.0% |
| Prostatic Disorder |
1.8% |
| Diabetes Mellitus |
1.5% |
| Gastrooesophageal Reflux Disease |
1.5% |
| Arthralgia |
1.5% |
| Erectile Dysfunction |
1.2% |
| Type 2 Diabetes Mellitus |
1.2% |
| Chronic Obstructive Pulmonary Disease |
1.1% |
|
| Weight Decreased |
11.3% |
| Flushing |
9.5% |
| Drug Ineffective |
8.8% |
| Vision Blurred |
6.7% |
| Weight Increased |
6.3% |
| Vomiting |
6.0% |
| Somnolence |
5.6% |
| Myocardial Infarction |
5.3% |
| Pruritus |
5.3% |
| Thrombocytopenia |
4.6% |
| Prostatic Specific Antigen Increased |
3.9% |
| Rash |
3.9% |
| Pain |
3.5% |
| Fatigue |
3.2% |
| Dyspepsia |
2.8% |
| Paraesthesia |
2.8% |
| Sepsis |
2.8% |
| Urticaria |
2.8% |
| Death |
2.5% |
| Mental Status Changes |
2.5% |
|
| Interacting |
| Prostatomegaly |
37.5% |
| Thrombosis Prophylaxis |
37.5% |
| Gastrointestinal Stromal Tumour |
12.5% |
| Hypertension |
12.5% |
|
| Drug Interaction |
25.0% |
| Haematoma |
25.0% |
| International Normalised Ratio Increased |
25.0% |
| Renal Failure Acute |
25.0% |
|
